Chloroquine phosphate syrup (Maxiquine) is indicated for the treatment of malaria, contraindicated in patients with known hypersensitivity to chloroquine or related compounds, may cause side effects such as gastrointestinal disturbances, headache, and visual changes, and can interact with drugs like antacids and certain anticonvulsants, potentially affecting its efficacy.